SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Hemant Surgical Industries Ltd

BSE: 543916 NSE: ISIN: INE0GYI01028
  |   Sector:  Healthcare   |   Industry:  Medical Equipment/Supplies/Accessories

Snapshot

Q.1 Which industry/sub-sector does Hemant Surgical Industries Ltd belong to?
Hemant Surgical Industries Ltd belongs to the Healthcare sector, operating specifically within the Medical Equipment/Supplies/Accessories segment.
Q.2 Is Hemant Surgical Industries Ltd a good quality company?
Hemant Surgical Industries Ltd is a quality company, based on a 10 year financial track record.
Q.3 Is Hemant Surgical Industries Ltd undervalued or overvalued?
Hemant Surgical Industries Ltd appears Overvalued, as its key valuation ratios are above with their past averages.
Q.4 Is Hemant Surgical Industries Ltd a good buy now?
Hemant Surgical Industries Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd revenue growth is 0.9% for FY-2025 , which is below its 5 year CAGR of 13.7% , indicating slower growth.
Q.2 Gross Profit margin of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd Gross profit margin which is the profit after deduction of direct costs, is 11.3% for FY-2025 , which is above its 5 year median of 10% , indicating increasing margins.
Q.3 Operating Profit Margin of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 9.73% for FY-2025 , which is above its 5 year median of 9.68% indicating increasing margins.
Q.4 Net Profit Margin of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd Net Profit Margin is 7.63% for FY-2025 , is above with its 5 year median of 7%, indicating increasing margins.
Current Level Historic Median
Gross Profit Margin 11.3 10
Operating Profit Margin 9.73 9.68
Net Profit Margin 7.63 7
Q.5 Return on Asset of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd Return on Asset is 6.57(x), which is below its 5 year historical median of 9.49(x), indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd Return on equity is 13.8% for FY-2025 , which is below its historical median of 25.06%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd Return on capital employed is 16.58% for FY-2025 , which is above its estimated weighted average cost of capital(WACC) 14%, indicating value creation.
Q.8 Cash conversion cycle of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd Cash conversion cycle is 77 , above its historical median of 30 , indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.86 1.42
ROE 13.8 25.06
ROCE 16.58 29.87
Cash Conversion Cycle 77 30
Q.9 Debt to Equity ratio of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd Debt-to-Equity ratio is 0.49 , which is above with the industry average of 0.36 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd Debt to cash flow from operations is 3.46 , which is at a unhealthy level, indicating the business is not able to service its debt comfortably.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Hemant Surgical Industries Ltd?
Promoters hold 58.90% of the Hemant Surgical Industries Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Hemant Surgical Industries Ltd vs industry peers?
Hemant Surgical Industries Ltd revenue CAGR is 13.68% , compared to the industry median CAGR of 1.45% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 106.5 36.5
Gross Profit 12.1 4.1
Operating Profit 9 3.3
Net Profit 8 2.6
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.86 0.73
ROE 13.8 15.79
ROCE 16.58 20.14
Cash Conversion Cycle 76.65 86

Valuation & price assessment

Q.1 Stock return of Hemant Surgical Industries Ltd over the last decade?
Over the last 9 years, the stock has delivered a CAGR of 0% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price - - - 185%
Q.3 Valuation ratios of Hemant Surgical Industries Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 47.35 21.33 148.25
Price to Book 3.37 4.32 3.50
Price to Sales 3.62 1.98 3.36
EV to EBITDA 28.41 14.05 19.40

Check more companies

1. Poly Medicure
2. Osel Devices
3. Laxmi Denta
4. 3B Blackbio Dx
5. Prevest Denpro
6. Hemant Surgical Inds
7. Yash Optics & Lens
8. Nureca Ltd.
9. Earkart
10. Raaj Medisafe India
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×